Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis beyond the cancer clone(s) in multiple myeloma
Giada Bianchi, Nikhil C. Munshi
Blood (2015) Vol. 125, Iss. 20, pp. 3049-3058
Open Access | Times Cited: 260

Showing 1-25 of 260 citing articles:

Multiple myeloma
Shaji Kumar, S. Vincent Rajkumar, Robert A. Kyle, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 958
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2019) Vol. 49, Iss. 10, pp. 1457-1973
Open Access | Times Cited: 876
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 2708-3145
Open Access | Times Cited: 318
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
Jinheng Wang, Kim De Veirman, Sylvia Faict, et al.
The Journal of Pathology (2016) Vol. 239, Iss. 2, pp. 162-173
Open Access | Times Cited: 211
Evolutionary biology of high-risk multiple myeloma
Charlotte Pawlyn, Gareth J. Morgan
Nature reviews. Cancer (2017) Vol. 17, Iss. 9, pp. 543-556
Closed Access | Times Cited: 211
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Jesús Delgado‐Calle, Judith Anderson, Meloney Cregor, et al.
Cancer Research (2016) Vol. 76, Iss. 5, pp. 1089-1100
Open Access | Times Cited: 195
Multiple Myeloma: Available Therapies and Causes of Drug Resistance
Vanessa Carla Monteiro Pinto, Rui Bergantim, Hugo R. Caires, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 192
Novel agents in the treatment of multiple myeloma: a review about the future
Leonard Naymagon, Maher Abdul‐Hay
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 171
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Almudena García-Ortiz, Yaiza Rodríguez‐García, Jessica Encinas, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 217-217
Open Access | Times Cited: 163
Pathobiology and Diagnosis of Multiple Myeloma
Kevin E. Brigle, Barbara Rogers
Seminars in Oncology Nursing (2017) Vol. 33, Iss. 3, pp. 225-236
Closed Access | Times Cited: 161
The bone-marrow niche in MDS and MGUS: implications for AML and MM
Irene M. Ghobrial, Alexandre Detappe, Kenneth C. Anderson, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 4, pp. 219-233
Closed Access | Times Cited: 144
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
Alison B. Shupp, Alexus D. Kolb, Dimpi Mukhopadhyay, et al.
Cancers (2018) Vol. 10, Iss. 6, pp. 182-182
Open Access | Times Cited: 125
Myeloid-derived suppressor cells: The green light for myeloma immune escape
Ehsan Malek, Marcos de Lima, John J. Letterio, et al.
Blood Reviews (2016) Vol. 30, Iss. 5, pp. 341-348
Open Access | Times Cited: 121
Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth
Jesús Delgado‐Calle, Judith L. Anderson, Meloney Cregor, et al.
Leukemia (2017) Vol. 31, Iss. 12, pp. 2686-2694
Open Access | Times Cited: 112
Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
Sylvie Hermouet, Edith Bigot–Corbel, Betty Gardie
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 99
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
Niels van Nieuwenhuijzen, Ingrid Spaan, Reinier Raymakers, et al.
Cancer Research (2018) Vol. 78, Iss. 10, pp. 2449-2456
Open Access | Times Cited: 92
Multiple myeloma: an overview of management
Sarah Bird, Kevin Boyd
Palliative Care and Social Practice (2019) Vol. 13
Open Access | Times Cited: 89
Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy
Min Yang, Yu Chen, Li Zhu, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 83-83
Open Access | Times Cited: 11
Promising therapies in multiple myeloma
Giada Bianchi, Paul G. Richardson, Kenneth C. Anderson
Blood (2015) Vol. 126, Iss. 3, pp. 300-310
Open Access | Times Cited: 89
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 10, pp. e401-e419
Open Access | Times Cited: 71
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
Anne Slomp, Victor Peperzak
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 71
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
Margaux Lejeune, Murat Cem Köse, Elodie Duray, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 70
Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers
Daniel D. Waller, Jaeok Park, Youla S. Tsantrizos
Critical Reviews in Biochemistry and Molecular Biology (2019) Vol. 54, Iss. 1, pp. 41-60
Closed Access | Times Cited: 68
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
Gianfranco Pittari, Luca Vago, Moreno Festuccia, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 67
Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
Maaike V.J. Braham, Monique C. Minnema, Tineke Aarts, et al.
OncoImmunology (2018) Vol. 7, Iss. 6
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top